Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort

Prevalence of Sleep Apnea in a Lung Cancer Screening Cohort Meeting NLST Criteria

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02687997

Acronym

SAILS

Enrollment

282

Registered

2016-02-23

Start date

2016-02-29

Completion date

2017-07-31

Last updated

2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Emphysema, Lung Cancer, Sleep Apnea Hypopnea Syndrome

Brief summary

Prospective study of sleep disordered breathing in a lung cancer screening cohort.

Detailed description

The proposed study is a prospective single arm study evaluating the prevalence of sleep disordered breathing in a cohort of lung cancer screening patients.

Interventions

OTHERpoligraphy

Sleep study

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

55 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* Age 55-75. * \> 30 pack years tobacco exposure. * Enrolled in lung cancer screening program.

Exclusion criteria

* Inability or unwillingness to undergo a home sleep study.

Design outcomes

Primary

Measure	Time frame
Prevalence of sleep apnea	1 year

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026